The Human Tissue Authority (HTA) is an Executive Non-Departmental Public Body (ENDPB) sponsored by the Department of Health and as such has a framework agreement (PDF). The Authority’s Chair and 11 Members were appointed by the Secretary of State for Health. The Chair and nine members are lay and the remaining two are professionals drawn from some of the groups with a direct interest in the application of the HT Act. The Authority is supported by an Executive of 47 staff. Papers and minutes of Authority meetings are available here.
With the interests of both the public and regulated establishments at the centre of its work, the HTA's strategic goal is to maintain and build confidence in the removal, storage and use of human tissue by ensuring that these activities are undertaken safely and ethically, and with proper consent. The strategic objectives that support this aim and information on how the HTA plans to achieve them are included in the Strategic Plan and the annual Business Plans. A simple introduction to the HTA, its role and objectives is available in the About the HTA section.
The HTA Business Plan 2018-19 and Strategy 2018-21 are also available.
The HTA is responsible for achieving its policies, aims and objectives, whilst safeguarding the public funds and assets. The Chief Executive, acts as the HTA’s Accounting Officer and is responsible for the overall organisation, management and staffing of the HTA and for ensuring that there is a high standard of financial management in the HTA.
The Chief Executive is accountable to the HTA Authority for the work of the Executive and the Authority is accountable to the Department of Health and Parliament for the activities and performance of the HTA.
At the end of each financial year, the HTA submits an Annual Report and Accounts to the Secretary of State, National Assembly for Wales and the relevant Northern Ireland Department.